Moderate

Chronic schistosomiasis

Schisto · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Chronic schistosomiasis results from egg-induced granulomatous inflammation: hepatosplenic/intestinal disease (S. mansoni/japonicum) or urogenital disease with bladder fibrosis and cancer risk (S. haematobium). Praziquantel treats active infection; complications need organ-specific care.

Red flags

  • Variceal haemorrhage (hepatosplenic disease)
  • Neuroschistosomiasis (myelopathy, seizures)
  • Obstructive uropathy/renal failure
  • Haematuria with suspected bladder carcinoma
  • Pulmonary hypertension

Assessment

Differential diagnosis

  • Other causes of portal hypertension (cirrhosis)
  • Bladder malignancy/other haematuria causes
  • Chronic hepatitis
  • Other intestinal parasitosis
  • Ectopic disease (neuroschistosomiasis, pulmonary hypertension)

Investigations

  • Stool (S. mansoni/japonicum) or urine (S. haematobium) microscopy for eggs
  • Schistosome serology (useful in travellers/light infection)
  • Ultrasound (liver/periportal fibrosis; bladder/urinary tract)
  • FBC (eosinophilia), liver and renal function
  • Urinalysis for haematuria (urogenital disease)
  • Endoscopy for varices in hepatosplenic disease

Management

  • Confirm species and infection with egg microscopy and/or serology
  • Assess organ involvement with ultrasound and relevant investigations
  • Treat active infection with praziquantel
  • Repeat/retreat as egg excretion and maturity dictate (praziquantel less active against immature worms)
  • Manage portal hypertension and varices in hepatosplenic disease
  • Manage urinary tract obstruction/fibrosis and screen for bladder cancer in urogenital disease
  • Consider corticosteroids for acute severe/ectopic inflammatory disease (e.g. neuroschistosomiasis)
  • Treat ectopic complications (spinal cord, pulmonary hypertension) with specialist input
  • Follow up with repeat parasitology to confirm cure
  • Counsel on reinfection risk and freshwater avoidance
  • Address co-infections (e.g. hepatitis) affecting the liver
  • Long-term surveillance for complications

Drugs & doses

Praziquantel 40 mg/kg PO (single dose or divided) for S. mansoni/haematobium
Praziquantel 60 mg/kg PO (divided) for S. japonicum/mekongi
Corticosteroids (e.g. prednisolone) adjunct for neuroschistosomiasis/severe acute inflammation
Repeat praziquantel at 4-6 weeks to target maturing worms in travellers

Disposition

Outpatient tropical medicine/ID; admit for complications (variceal bleed, neuroschistosomiasis); long-term surveillance.

Complications & pitfalls

  • Periportal (Symmers) fibrosis and portal hypertension
  • Bladder fibrosis, obstruction and squamous cell carcinoma
  • Neuroschistosomiasis
  • Pulmonary hypertension
  • Chronic anaemia and growth impairment

Exam pearls

  • Praziquantel is poorly active against immature worms - repeat dosing in recent/travel infection
  • Urogenital schistosomiasis is a risk factor for bladder squamous cell carcinoma
  • Serology aids diagnosis in light infections and returning travellers
  • Egg-induced fibrosis may persist despite cure of active infection
  • Consider neuroschistosomiasis in unexplained myelopathy after freshwater exposure

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.